LLY and Amplitude Therapeutics collaborate on trans-amplifying RNA vaccines
LLY and Amplitude Therapeutics enter a strategic collaboration to develop trans-amplifying RNA vaccines for infectious diseases, according to Hammerstone MarketTalk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.